tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joseph Thome, 66 are a BUY (81.48%), 15 are a HOLD (18.52%).
Analyst Joseph Thome, currently employed at TD COWEN, carries an average stock price target met ratio of 53.5% that have a potential upside of 99.28% achieved within 175 days.
Joseph Thome’s has documented 163 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on UTHR, United Therapeutics at 05-Nov-2026.
Analyst best performing recommendations are on CMRX (CHIMERIX).
The best stock recommendation documented was for PTCT (PTC THERAPEUTICS) at 7/20/2020. The price target of $50 was fulfilled within 1 day with a profit of $3.29 (6.17%) receiving and performance score of 61.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Sep-2022
$272
$139.63 (105.48%)
$316
8 days ago
(04-Nov-2026)
43/47 (91.49%)
$135 (98.54%)
204
Buy Since 16-Oct-2019
$250
$117.63 (88.86%)
$275
9 days ago
(03-Nov-2026)
18/21 (85.71%)
$113.99 (83.81%)
430
Hold Since 30-Apr-2026
$249
$116.63 (88.11%)
$247
9 days ago
(03-Nov-2026)
8/11 (72.73%)
$112.99 (83.07%)
152
Buy Since 18-Mar-2024
$220
$87.63 (66.20%)
$246
9 days ago
(03-Nov-2026)
10/11 (90.91%)
$83.99 (61.75%)
163
Buy Since 06-Feb-2024
$239
$106.63 (80.55%)
$259
9 days ago
(03-Nov-2026)
8/10 (80%)
$102.99 (75.72%)
174
Which stock is Joseph Thome most bullish on?
Which stock is Joseph Thome most reserved on?
What Year was the first public recommendation made by Joseph Thome?
